NCT02080715View on ClinicalTrials.gov

Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Healthy
Interventions
DRUG

Tolcapone

2 x 100mg Tolcapone compared to placebo (randomized, double-blind, cross-over)

DRUG

Placebo

Trial Locations (1)

Unknown

University of Zurich, Institute of Pharmacology and Toxicology, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT02080715 - Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance | Biotech Hunter | Biotech Hunter